Leadership Overview
Van Andel Institute has 5 executives leading key functions including strategy, science, operations, technology, and people.
Driven by a commitment to discovery, Van Andel Institute advances biomedical research and science education, aiming to improve health and enhance lives for current and future generations through rigorous scientific inquiry and impactful educational initiatives.
Driven by a commitment to discovery, Van Andel Institute advances biomedical research and science education, aiming to improve health and enhance lives for current and future generations through rigorous scientific inquiry and impactful educational initiatives.
Leadership Roles at Van Andel Institute
David Van Andel - Chairman & Chief Executive Officer
David Van Andel, the Chairman & Chief Executive Officer at Van Andel Institute, directs the overall strategic vision and operational execution of the organization. This leadership role involves guiding Van Andel Institute's mission to improve health and enhance lives through biomedical research and science education. Van Andel oversees the institute's long-term planning, ensuring alignment with its core objectives and market position within the nonprofit biomedical sector. The Chairman & Chief Executive Officer drives the organization's financial health and resource allocation, fostering an environment of scientific innovation and educational excellence. David Van Andel's leadership ensures the institute's continued growth and impact in Grand Rapids, Michigan, and beyond, solidifying its commitment to advancing scientific understanding and its application for societal benefit.
Timothy Myers - Vice President, Chief Administrative Officer and Chief Financial Officer
Timothy Myers, the Vice President, Chief Administrative Officer and Chief Financial Officer at Van Andel Institute, directs the organization's financial operations and administrative functions. This multifaceted role encompasses fiscal management, budgeting, financial planning, and resource allocation to support the institute's research and educational endeavors. Myers oversees administrative departments, ensuring operational efficiency and compliance with regulatory standards. The Vice President, Chief Administrative Officer and Chief Financial Officer plays a key part in managing the institute's assets and financial sustainability, enabling the pursuit of groundbreaking biomedical discoveries. Timothy Myers's financial acumen and administrative oversight are vital to Van Andel Institute's mission, ensuring robust support for scientific advancement and operational excellence.
Jonathan Licht - President & Chief Scientific Officer
Jonathan Licht, the President & Chief Scientific Officer at Van Andel Institute, spearheads the institute's scientific research agenda and oversees all laboratory operations. This leadership position drives the strategic direction of biomedical research, focusing on critical areas aimed at improving human health. Licht guides the scientific community within Van Andel Institute, fostering an environment of collaboration and discovery. The President & Chief Scientific Officer ensures the integrity and impact of the institute's research output, aligning scientific pursuits with the overarching mission. Jonathan Licht's scientific vision and leadership are fundamental to Van Andel Institute's reputation as a leading center for biomedical research and its commitment to translating scientific findings into tangible health benefits.

Shane Newmyer - Chief Information Officer
Shane Newmyer, the Chief Information Officer at Van Andel Institute, architects and manages the institute's comprehensive technology infrastructure and digital strategy. This critical role ensures the seamless operation of all IT systems, supporting cutting-edge biomedical research and science education initiatives. Newmyer oversees data security, network integrity, and the implementation of advanced technological solutions that empower scientific discovery. The Chief Information Officer drives innovation in information management, ensuring that researchers and educators have access to the tools and resources necessary for their work. Shane Newmyer's leadership in technology directly contributes to Van Andel Institute's ability to analyze complex biological data, facilitate collaboration, and maintain a secure, efficient digital environment for all operations across the United States.

Julie Nuter - Chief People Officer
Julie Nuter, the Chief People Officer at Van Andel Institute, leads the human resources strategy and talent management initiatives, fostering a vibrant and productive organizational culture. This position is central to attracting, developing, and retaining top scientific and administrative talent, crucial for advancing the institute's mission. Nuter oversees all aspects of employee relations, compensation, benefits, and professional development programs. The Chief People Officer ensures that Van Andel Institute cultivates an inclusive environment that supports scientific innovation and collaboration. Julie Nuter's dedication to people operations directly impacts the institute's capacity to achieve its goals in biomedical research and science education, reinforcing its commitment to its workforce as a key asset.
Explore Leadership Teams in Business Services
Intertek is a global provider of quality and safety services across diverse industries. Founded in 1885, the company offers testing, inspection, certification, and consulting solutions to ensure products and processes meet regulatory standards and quality requirements. Intertek serves clients worldwide with operations spanning North America, Europe, Asia, Africa, and the Middle East, delivering specialized research and development services along with technical expertise to help businesses manage risk and improve performance.
Company Leadership
PA
NS
SV
We are delighted to announce that our company name will be changing to Allucent. Purpose-built through the convergence of several leading providers, Allucent is a global provider of comprehensive drug development solutions across a variety of therapeutic areas with more than 30 years of experience and operations in over 60 countries. Our individualized partnership approach provides experience-driven insights and expertise to assist our clients in successfully navigating the complexities of delivering novel treatments to patients who need them.
Company Leadership AE
PS


Founded in 1981 and headquartered in Waltham, Massachusetts, Repligen is a bioprocessing-focused life sciences company that is inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.
Company Leadership OL
MM

MS
Softys provides business services. Contact them directly for more information about their offerings.
Company Leadership MP
AB
Gd